Our purpose is to determine whether 13D-10 Fab administration to human subjects 1) is safe and nontoxic, 2) causes a predictable decline in factor VII activity, and 3) leads to recovery of factor VII activity due to the production of unhindered factor VII.
Showing the most recent 10 out of 570 publications